rs878853119
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_001567.4(INPPL1):c.24_39del(p.Gly9TrpfsTer13) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Consequence
INPPL1
NM_001567.4 frameshift
NM_001567.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.793
Genes affected
INPPL1 (HGNC:6080): (inositol polyphosphate phosphatase like 1) The protein encoded by this gene is an SH2-containing 5'-inositol phosphatase that is involved in the regulation of insulin function. The encoded protein also plays a role in the regulation of epidermal growth factor receptor turnover and actin remodelling. Additionally, this gene supports metastatic growth in breast cancer and is a valuable biomarker for breast cancer. [provided by RefSeq, Jan 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.996 CDS is truncated, and there are 2 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 11-72224999-CGGGGCGCCGGGCCCGG-C is Pathogenic according to our data. Variant chr11-72224999-CGGGGCGCCGGGCCCGG-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 242401.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
INPPL1 | NM_001567.4 | c.24_39del | p.Gly9TrpfsTer13 | frameshift_variant | 1/28 | ENST00000298229.7 | NP_001558.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INPPL1 | ENST00000298229.7 | c.24_39del | p.Gly9TrpfsTer13 | frameshift_variant | 1/28 | 1 | NM_001567.4 | ENSP00000298229 | P1 | |
INPPL1 | ENST00000540973.1 | c.24_39del | p.Gly9TrpfsTer? | frameshift_variant | 2/2 | 3 | ENSP00000440904 | |||
INPPL1 | ENST00000543234.1 | c.24_39del | p.Gly9TrpfsTer? | frameshift_variant | 2/2 | 2 | ENSP00000440512 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Opsismodysplasia Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | DASA | Feb 05, 2022 | The c.24_39del;p.(Gly9Trpfs*13) is a null frameshift variant (NMD) in the INPPL1 gene and predicts alteration of the nonsense-mediate decay - NMD is present in a relevant exon to the transcript - PVS1. This variant is not present in population databases (rs878853119, gnomAD; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2. In summary, the currently available evidence indicates that the variant is likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at